Category Archives: Kyle Dennis Biotech Nucleus

The market is stalling at all-time highs… and traders are still trying to piece together the puzzle… However, I’m not one of those traders. Why? I’m focused on trading biotech stocks — they offer explosive opportunities and move at their … Continue reading →

The market is at all-time highs… and the “million-dollar” question is whether you pile in short to play for a pullback… or position yourself for the Santa Claus rally? This price action has many traders confused and scrambling to find … Continue reading →

I’m sure you’ve heard the news by now… LVMH, the parent company of Louis Vuitton offered to buy out Tiffany’s (TIF) for $14.5B. Source: Bloomberg If you were up bright and early to catch that headline, you would’ve been lucky … Continue reading →

For 39 trading days… I’ve been following some of the top options traders on Wall Street…  sniffing out their best trade setups… So far, I’ve taken 51 trades and achieved an 80% win rate… and many of these trades have … Continue reading →

If you’re waking up every Monday morning in a rush… trying to find just the right play that will put you in a position to find money-making opportunities… but come up short, I’ve got the perfect solution for you — … Continue reading →

Ready To Try Dollar Ace?Click Here To Find Your Bonuses Bulls vs. Bears, it’s a never-ending fight between the parties. Like two grizzled politicians struggling to win over the public’s sentiment. But any savvy trader will tell you: there is … Continue reading →

Stocks still can’t seem to figure out whether they want to break out to new highs or revisit the summer lows… However, traders remain hypersensitive to news headlines—causing a lot of back and forth price action. During periods of uncertainty, … Continue reading →

It’s been a sloppy start to October… as geopolitical tensions steal headlines from an already jam-packed news-driven market. There’s so much noise right now that it’s been hard to find great setups and follow through… even seasoned traders are finding … Continue reading →

When you think about trading biotech or pharmaceutical stocks… the first thing that pops into most people’s mind is, Johnson & Johnson, Merck & Co. or Novartis… Companies like Melinta Therapeutics and Chiasma are foreign to most casual traders. However, if … Continue reading →

It’s shaping up to be a red October… Only a few days in and we’ve already experienced immense volatility, as the S&P 500 is on pace for its worst quarterly performance in well over a decade. And while I wasn’t … Continue reading →